早期胃癌诊断与治疗策略

Diagnosis and treatment strategies of early gastric cancer

  • 摘要: 随着胃镜筛查普及及诊疗技术发展,早期胃癌检出率持续上升,其治疗目标由单纯肿瘤根治逐步转向兼顾器官保留、功能维持及生命质量改善。早期胃癌精准诊疗依赖高质量术前评估,综合病灶位置、大小、组织学类型、浸润深度及淋巴结转移风险,可为内镜治疗、保功能手术或标准根治术的方案选择提供依据。在诊断进展方面,新一代电子染色内镜、放大内镜、共聚焦激光显微内镜及人工智能辅助系统可实现病灶定位、性质判定及切缘评估,显著提高检出率和诊断一致性。术前评估还需前瞻性识别非治愈性切除风险,为内镜术后追加外科手术提供参考。治疗进展方面,以内镜黏膜下剥离术为代表的内镜治疗可实现肿瘤整块切除及完整病理学评估,但该手术方式仅适用于病理学评估达到治愈性切除标准且淋巴结转移风险极低的患者;非治愈性切除患者需在风险分层指导下追加外科手术。外科治疗由标准根治术向功能导向、精准外科转变,包括保留幽门胃切除术、近端胃切除术、前哨淋巴结导航及腹腔镜‑内镜联合手术等,实现根治与功能保护并重。由于胃癌淋巴结转移可出现跳跃性转移等特点,早期胃癌前哨淋巴结导航的临床应用目前尚难达成广泛共识。早期胃癌诊疗强调内镜与外科协同、术前风险分层及多学科管理,在肿瘤根治和功能保全之间寻找最大“平衡点”是未来研究的方向。

     

    Abstract: With the widespread implementation of endoscopic screening, advances in endo-scopic diagnostic technologies, and updates in clinical management concepts, the detection rate of early gastric cancer (EGC) has steadily increased. The treatment goal has gradually shifted from merely achieving oncologic cure to balancing tumor eradication with organ preservation, functional main-tenance, and quality of life. Precision management of EGC relies on high‑quality preoperative evaluation, incorporating tumor location, size, histology, invasion depth, and lymph node metastasis risk to guide the choice among endoscopic therapy, function‑preserving surgery, or standard radical gastrectomy. In terms of diagnostic progress, novel endoscopic techniques, including next-generation image-enhanced endoscopy, magnifying endoscopy, confocal laser endomicroscopy, and artificial intelligence-assisted systems, allow precise lesion localization, characterization, and margin assess-ment, signifi-cantly improving early lesion detection and diagnostic consistency. Preoperative assessment should also prospectively identify patients at risk for non‑curative endoscopic resection, providing guidance for subsequent surgical planning. Regarding therapeutic advances, endoscopic submucosal dissection enables en bloc resection and comprehensive pathological evaluation, yet its indications remain constrained by histologic curability and low lymph node metastasis risk; patients with non‑curative resection require risk‑stratified additional surgery. Surgical management is evolving from standard radical gastrectomy to function‑preserving and precision approaches, including pylorus-preserving gastrectomy, proximal gastrectomy, sentinel lymph node navigation, and laparoscopy-endoscopy cooperative procedures, integrating oncologic control with functional preservation. Although sentinel lymph node navigation can optimize nodal clearance, its accuracy is limited by skip and micro-metastatic spread. Overall, EGC management emphasizes the synergistic integration of endoscopic and surgical approaches, preoperative risk stratification, and multidisci-plinary coordination. The paradigm is moving beyond simply answering "can it be resected? "toward achieving" precise resection, functional preservation, and improved long‑term outcomes".

     

/

返回文章
返回